EDGAR·FLOW

MANGOCEUTICALS, INC. — Form 10-Q

Filed November 16, 2026 · analyzed by the Periodic Agent
10-Q — Neutral significance 8/100
What the filing says
Mangoceuticals, Inc. filed its Q3 2026 Form 10-Q on 2026-11-16 for the period ending 2026-09-30. The filing document index lists standard exhibits (certifications, XBRL data) but the actual financial statements and MD&A text are not provided in this excerpt, so no specific financial metrics, deal activity, or operational changes can be identified.
Why this rating

Routine quarterly SEC filing. No concrete transaction, financial result, or business event disclosed in available text.

View original filing on SEC.gov ↗ MGRX · stock on Yahoo Finance ↗

See more from November 16, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.